152 related articles for article (PubMed ID: 16139319)
21. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
[TBL] [Abstract][Full Text] [Related]
22. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
[TBL] [Abstract][Full Text] [Related]
23. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
González-Carmona MA; Vogt A; Heinicke T; Quasdorff M; Hoffmann P; Yildiz Y; Schneider C; Serwe M; Bartenschlager R; Sauerbruch T; Caselmann WH
J Hepatol; 2011 Jul; 55(1):19-28. PubMed ID: 21145870
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
[TBL] [Abstract][Full Text] [Related]
26. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
Lee KJ; Choi J; Ou JH; Lai MM
J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
[TBL] [Abstract][Full Text] [Related]
27. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
28. Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon.
Shimakami T; Honda M; Kusakawa T; Murata T; Shimotohno K; Kaneko S; Murakami S
J Virol; 2006 Apr; 80(7):3332-40. PubMed ID: 16537600
[TBL] [Abstract][Full Text] [Related]
29. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
[TBL] [Abstract][Full Text] [Related]
30. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
31. Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication.
Goh PY; Tan YJ; Lim SP; Tan YH; Lim SG; Fuller-Pace F; Hong W
J Virol; 2004 May; 78(10):5288-98. PubMed ID: 15113910
[TBL] [Abstract][Full Text] [Related]
32. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background.
Graham DJ; Stahlhut M; Flores O; Olsen DB; Hazuda DJ; Lafemina RL; Ludmerer SW
Antiviral Res; 2006 Jan; 69(1):24-30. PubMed ID: 16297457
[TBL] [Abstract][Full Text] [Related]
33. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
[TBL] [Abstract][Full Text] [Related]
34. Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper.
Welker MW; Susser S; Welsch C; Perner D; Füller C; Kronenberger B; Herrmann E; Zeuzem S; Sarrazin C
J Viral Hepat; 2012 Nov; 19(11):775-83. PubMed ID: 23043384
[TBL] [Abstract][Full Text] [Related]
35. Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient sera.
Tripathi RL; Krishnan P; He Y; Middleton T; Pilot-Matias T; Chen CM; Lau DT; Lemon SM; Mo H; Kati W; Molla A
Antiviral Res; 2007 Jan; 73(1):40-9. PubMed ID: 16914212
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
Korf M; Jarczak D; Beger C; Manns MP; Krüger M
J Hepatol; 2005 Aug; 43(2):225-34. PubMed ID: 15964661
[TBL] [Abstract][Full Text] [Related]
37. The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells.
Murayama A; Date T; Morikawa K; Akazawa D; Miyamoto M; Kaga M; Ishii K; Suzuki T; Kato T; Mizokami M; Wakita T
J Virol; 2007 Aug; 81(15):8030-40. PubMed ID: 17522229
[TBL] [Abstract][Full Text] [Related]
38. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.
Howe AY; Cheng H; Johann S; Mullen S; Chunduru SK; Young DC; Bard J; Chopra R; Krishnamurthy G; Mansour T; O'Connell J
Antimicrob Agents Chemother; 2008 Sep; 52(9):3327-38. PubMed ID: 18559648
[TBL] [Abstract][Full Text] [Related]
40. RacGTPase-activating protein 1 interacts with hepatitis C virus polymerase NS5B to regulate viral replication.
Wu MJ; Ke PY; Horng JT
Biochem Biophys Res Commun; 2014 Nov; 454(1):19-24. PubMed ID: 25305482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]